Male birth control pill clears initial safety hurdle

YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non‑hormonal male contraceptive YCT‑529 up to 180 mg produced no clinically relevant safety issues ...

Low testosterone linked to cancer risk in men

New research shows men with very low testosterone levels are at higher risk of both fatal and nonfatal cancer later in life. But while the research found men with low testosterone were 18% more likely to die of cancer years ...

page 1 from 35